Glenmark Pharma gets tentative USFDA nod for Clindamycin Phosphate Foam

According to IQVIA sales data for the 12-month period ending April 2019, the EVOCLIN Foam, 1% market achieved annual sales of approximately $17.0 million.

from India Infoline News Service http://bit.ly/2XoRaSf